This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Enzo Life Sciences
other brands :
Stressgen, BioMol, Alexis Corporation, Assay Designs, Alexis
product type :
chemical
product name :
Gabapentin
catalog :
BML-CA234-0100
quantity :
100 mg
citations: 3
Reference |
---|
Baillie J, Power I. The mechanism of action of gabapentin in neuropathic pain. Curr Opin Investig Drugs. 2006;7:33-9 pubmed
|
Schwarz J, Gibbons S, Graham S, Colbry N, Guzzo P, Le V, et al. Novel cyclopropyl beta-amino acid analogues of pregabalin and gabapentin that target the alpha2-delta protein. J Med Chem. 2005;48:3026-35 pubmed
|
Stahl S. Mechanism of action of alpha2delta ligands: voltage sensitive calcium channel (VSCC) modulators. J Clin Psychiatry. 2004;65:1033-4 pubmed
|
product information
Product ID :
BML-CA234
Catalog Number :
BML-CA234-0100
Product Name :
Gabapentin
Product Type :
Biochemical
Size :
100 mg
list of Pubmed id :
16425669, 15828841, 15323585
Product Description :
Gabapentin is a GABA analog which does not act at GABA receptors but which inhibits L-type calcium channels via binding to the α2-δ subunit and neuropathic pain relieving actions. Ligands acting at the α2-δ subunit lead to anticonvulsant, anxiolytic and neuropathic pain-relieving actions.
Purity :
≥98% (HPLC)
Storage :
Ambient
company information
Enzo Life Sciences
5777 Hines Drive
Ann Arbor, MI 48108
Ann Arbor, MI 48108
info-us@enzolifesciences.
https://www.enzolifesciences.com1-800-942-0430
headquarters: USA
Enzo Life Sciences, incorporating ALEXIS® Biochemicals and BIOMOL® International, offers a comprehensive panel of innovative life science reagents. Antibodies, enzymes, proteins, small molecule inhibitors, product libraries, and assay kits are available for research in Cancer, Cell Death, Epigenetics, Genomics, Immunology, Neuroscience, Signal Transduction, and Ubiquitin & Proteasomes, Enabling Discovery in Life Science(tm). Visit www.enzolifesciences.com.
questions and comments